Argent Trust CO Vertex Pharmaceuticals Inc Transaction History

Argent Trust CO

$2.38 Billion
Q1 2025

A detailed history of Argent Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Argent Trust CO holds 2,904 shares of VRTX stock, worth $1.29 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,904

Previous 3,294 11.84%

Holding current value

$1.29 Million

Previous $1.33 Million 6.11%

% of portfolio

0.06%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$402.49 - $513.76 $156,971 - $200,366	-390 Reduced 11.84%	2,904 $1.41 Million
Q4 2024 Feb 13, 2025	BUY	$396.64 - $516.74 $396 - $516	1 Added 0.03%	3,294 $1.33 Million
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $22,540 - $24,783	49 Added 1.51%	3,293 $1.53 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $7,463 - $9,225	19 Added 0.59%	3,244 $1.52 Million
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $88,468 - $96,799	217 Added 7.21%	3,225 $1.35 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $147,833 - $177,003	431 Added 16.72%	3,008 $1.22 Million
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $30,436 - $32,621	90 Added 3.62%	2,577 $896,000
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $71,687 - $80,235	228 Added 10.09%	2,487 $875,000
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $32,005 - $36,005	-112 Reduced 4.72%	2,259 $652,000
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $10,953 - $12,221	-40 Reduced 1.66%	2,371 $686,000
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $77,497 - $91,339	-350 Reduced 12.68%	2,411 $629,000
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $80,362 - $101,446	454 Added 19.68%	2,761 $606,000
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $23,580 - $26,388	-130 Reduced 5.33%	2,307 $418,000
Q2 2021 Aug 09, 2021	BUY	$187.49 - $221.1 $95,807 - $112,982	511 Added 26.53%	2,437 $491,000
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $47,614 - $55,501	-230 Reduced 10.67%	1,926 $413,000
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $49,061 - $65,433	237 Added 12.35%	2,156 $510,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $4,601 - $5,455	-18 Reduced 0.93%	1,919 $522,000
Q2 2020 Aug 04, 2020	SELL	$225.48 - $295.8 $65,614 - $86,077	-291 Reduced 13.06%	1,937 $563,000
Q1 2020 May 11, 2020	SELL	$199.77 - $247.81 $23,373 - $28,993	-117 Reduced 4.99%	2,228 $530,000
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $33,675 - $45,229	202 Added 9.43%	2,345 $514,000
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $166,230 - $187,090	1,000 Added 87.49%	2,143 $362,000
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $188,149 - $217,592	1,143 New	1,143 $209,000

Others Institutions Holding VRTX

# of Institutions

1,831

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $114B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account